Bad Medical is a medical technology enterprise specializing in the research, development, production and sales of minimally invasive oncology treatment equipment and consumables. With an experienced management team and a group of technologically advanced researchers, the company is committed to providing safer and more effective treatment solutions for global tumor patients.
The IPO will provide the company with more financial support, accelerate product development and market expansion, and lay a solid foundation for the company's long-term development.